References
Gotlib J, Cools J. Five years since the discovery of FIP1-PDGFR: what we have learned about the fusion and other molecularly defined eosinophilias. Leukemia. 2008;22:1999–2010.
Fletcher S, Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol. 2007;14:37–42.
Epstein F. Eosinophilia. N Engl J Med. 1998;338:1592–600.
Valent P. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev. 2009;23:157–65.
Pandit R, Scholnik A, Wulfekuhler L, Dimitrov N. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol. 2007;82:234–7.
Uemura K, Nakajima M, Yamauchi N, Fukayama M, Yoshida K. Sudden death of a patient with primary hypereosinophilia, colon tumors, and pulmonary emboli. J Clin Pathol. 2004;57:541–3.
Anagnostopoulos G, Sakorafas G, Kostopoulos P, Margantinis G, Tsiakos S, Terpos E, et al. Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF. J Surg Oncol. 2005;89:273–5.
Kimura T, Mukai M, Kaneko Y, Hirakata M, Okamoto S, Sakamoto M, et al. Unusual hemangioendothelioma of the liver with epitheloid morphology associated with marked eosinophilia: Autopsy case. Pathol Int. 2007;56:694–701.
Plumas J, Gruart V, Aldebert D, Truong J, Capron M, Capron L, et al. Human eosinophils from hypereosinophilic patients spontaneously express the p55 but not the p75 interleukin 2 receptor subunit. Eur J Immunol. 1990;21:1265–70.
Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, et al. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood. 1991;78:2626–32.
Collins P, Marleau S, Griffiths-Johnson D, Jose P, Williams T. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995;182:1169–74.
Acknowledgments
The authors thank the staff of the Department of Hematology and Rheumatology, Tohoku University for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kato, H., Kohata, K., Yamamoto, J. et al. Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer. Int J Hematol 91, 328–330 (2010). https://doi.org/10.1007/s12185-010-0491-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0491-2